Trade Arcadia Biosciences, Inc. - RKDA CFD
Add to favourite- Summary
- Historical Data
- Events
Spread | 0.08 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 2.21 |
Open* | 2.19 |
1-Year Change* | -70.95% |
Day's Range* | 2.16 - 2.25 |
52 wk Range | N/A |
Average Volume (10 days) | N/A |
Average Volume (3 months) | N/A |
Market Cap | N/A |
P/E Ratio | N/A |
Shares Outstanding | N/A |
Revenue | N/A |
EPS | N/A |
Dividend (Yield %) | N/A |
Beta | N/A |
Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 2.24 | 0.00 | 0.00% | 2.24 | 2.25 | 2.16 |
Mar 27, 2024 | 2.21 | -0.03 | -1.34% | 2.24 | 2.29 | 2.18 |
Mar 26, 2024 | 2.27 | 0.08 | 3.65% | 2.19 | 2.30 | 2.19 |
Mar 25, 2024 | 2.25 | 0.07 | 3.21% | 2.18 | 2.26 | 2.18 |
Mar 22, 2024 | 2.23 | 0.05 | 2.29% | 2.18 | 2.23 | 2.18 |
Mar 21, 2024 | 2.19 | -0.16 | -6.81% | 2.35 | 2.56 | 2.15 |
Mar 20, 2024 | 2.33 | 0.00 | 0.00% | 2.33 | 2.35 | 2.33 |
Mar 19, 2024 | 2.36 | -0.02 | -0.84% | 2.38 | 2.40 | 2.33 |
Mar 18, 2024 | 2.41 | -0.03 | -1.23% | 2.44 | 2.46 | 2.36 |
Mar 15, 2024 | 2.51 | 0.02 | 0.80% | 2.49 | 2.51 | 2.49 |
Mar 14, 2024 | 2.47 | 0.02 | 0.82% | 2.45 | 2.47 | 2.43 |
Mar 13, 2024 | 2.49 | 0.04 | 1.63% | 2.45 | 2.50 | 2.43 |
Mar 12, 2024 | 2.47 | -0.08 | -3.14% | 2.55 | 2.55 | 2.45 |
Mar 11, 2024 | 2.45 | -0.07 | -2.78% | 2.52 | 2.52 | 2.42 |
Mar 8, 2024 | 2.48 | 0.02 | 0.81% | 2.46 | 2.48 | 2.44 |
Mar 7, 2024 | 2.45 | 0.04 | 1.66% | 2.41 | 2.46 | 2.40 |
Mar 6, 2024 | 2.49 | -0.09 | -3.49% | 2.58 | 2.59 | 2.42 |
Mar 5, 2024 | 2.56 | -0.05 | -1.92% | 2.61 | 2.62 | 2.48 |
Mar 4, 2024 | 2.64 | -0.02 | -0.75% | 2.66 | 2.71 | 2.63 |
Mar 1, 2024 | 2.71 | -0.05 | -1.81% | 2.76 | 2.76 | 2.71 |
Arcadia Biosciences, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Arcadia Biosciences, Inc. Company profile
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc is engaged in developing crop improvements. The Company develops crops in wheat, soy and hemp, designed for farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products for industrial applications. It uses breeding techniques to develop. The Company's GoodWheat product ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Its GoodHemp seed catalog delivers hemp seeds, transplants and extracts. It offers Sonova GLA Safflower Oil by growing safflower plants producing seed which are high in gamma-linolenic acid (GLA). It also offers its Sonova GLA as a nutritional additive to adult dry dog and cat food formulations.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Arcadia Biosciences Inc revenues increased from $904K to $4.6M. Net loss decreased 60% to $5.4M. Revenues reflect SubTotal increase from $630K to $4.5M, Royalty increase of 48% to $86K. Lower net loss reflects Other income, net increase from $82K to $10.2M (income), Research and development - Balancing decrease of 63% to $2.1M (expense), Valuation of Inventory - Gain/Loss decrease of 39% to $1.8M (expense).
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com